For the quarter ending 2025-09-30, BLFS had -$2,421K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | 621 | -16,286 |
| Depreciation | 636 | 1,356 |
| Amortization of intangible assets | 699 | 1,410 |
| Stock-based compensation | 5,904 | 10,012 |
| Non-cash lease expense | 1,323 | 670 |
| Deferred income tax expense (benefit) | 14 | 51 |
| Change in fair value of investments, inclusive of interest | 41 | 0 |
| Accretion of available-for-sale investments | 230 | 305 |
| Gain on disposal of property and equipment, net | 0 | 0 |
| Loss on disposal of assets held for rent, net | -167 | -343 |
| Ipr&d expense | 0 | 15,521 |
| Loss on disposal of global cooling | 0 | 0 |
| Accounts receivable, trade, net | 782 | 892 |
| Inventories | 197 | -1,260 |
| Prepaid expenses and other assets | 3,000 | -423 |
| Accounts payable | -679 | -455 |
| Accrued expenses and other current liabilities | 1,564 | -3,388 |
| Sales taxes payable | 105 | -625 |
| Other | 0 | 0 |
| Net cash provided by operating activities | 6,104 | 9,095 |
| Purchases of available-for-sale securities | 13,090 | 64,303 |
| Proceeds from sale of available-for-sale securities | 1,836 | 1,755 |
| Maturities of available-for-sale securities | 10,962 | 8,390 |
| Purchases of assets held for rent | 373 | 412 |
| Purchases of property and equipment | 3,302 | 1,918 |
| Investment in ipr&d | 0 | 10,221 |
| Investment in convertible promissory note | 2,000 | - |
| Payments on divestiture of global cooling | 0 | 0 |
| Net cash used in investing activities | -5,967 | -66,709 |
| Payments on equipment loans | 0 | 0 |
| Proceeds from exercises of common stock options | 0 | 18 |
| Payments on term loans | 2,500 | 5,000 |
| Proceeds from financed insurance premium | 0 | - |
| Payments on financed insurance premium | 67 | 908 |
| Other | 9 | 20 |
| Net cash used in financing activities | -2,558 | -5,870 |
| Net decrease in cash and cash equivalents | -2,421 | -63,484 |
| Cash and cash equivalents at beginning of period | 95,386 | - |
| Cash and cash equivalents at end of period | 29,481 | - |
BIOLIFE SOLUTIONS INC (BLFS)
BIOLIFE SOLUTIONS INC (BLFS)